Ángel Carracedo: ''Only 50% of First-Line Drugs are Effective''
News Mar 20, 2013
Currently only 50% of first-line drugs are effective and adverse effects of drugs are the fourth leading cause of death in the United States and the eighth in Europe. According to Angel Carracedo "two individuals do not respond equal to a drug in health conditions, let alone in terms of disease. One of the factors that determine this response is genetics."
Knowing patient's genetics could allow administer only appropriate medications and save the patient from adverse effects of those drugs which wouldn't be effective. In fact, as explained Carracedo, the FDA and the EMEA (the drug regulatory agencies in the U.S. and Europe respectively) have made several recommendations in the data sheet of various drugs, especially in chemotherapy, so that it is mandatory genetic testing before prescribing them. However Carracedo has warned that "not all clinicians get this information and it is not always used properly."
"We must keep working," said Carracedo "in validating new biomarkers with an acceptable cost/effectiveness and find ways of implementing pharmacogenetics in the most efficient way in clinical practice."
Heart-on-a-chip Manufactured More Efficiently to Speed Up Drug TestingNews
Testing new clinical drugs' effect on heart tissue could become quicker and more straightforward, thanks to new research from Harvard University.
The study, sets out a new, faster method for manufacturing a 'heart-on-a-chip', which can be used to test the reaction of heart tissue to external stimuli.
Protein's Role in Mitochondrial Metabolism IdentifiedNews
EXD2, a protein previously thought to be localised to the nucleus, has a key role in the production of proteins by mitochondria.READ MORE
PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug DevelopmentNews
Will shorten timelines, reduce costs and simplify contracting process in pediatric programs.READ MORE